Share Price and Basic Stock Data
Last Updated: February 12, 2026, 9:33 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Thirumalai Chemicals Ltd operates within the specialty chemicals sector, focusing on various chemical formulations. The company reported total sales of ₹2,132 Cr for the fiscal year ending March 2023, a notable increase from ₹1,998 Cr in the previous fiscal year. However, the revenue trend shows fluctuations, with quarterly sales peaking at ₹572 Cr in September 2022 and declining to ₹431 Cr by March 2023. In the subsequent quarters, sales showed some recovery, standing at ₹542 Cr in September 2023. Despite these fluctuations, the company recorded a trailing twelve-month (TTM) revenue of ₹1,865 Cr, indicating a consistent demand for its products. The revenue from operations per share was ₹200.15, reflecting the company’s operational scale. However, the operating profit margin (OPM) has been under pressure, reaching -1% for September 2023, suggesting challenges in maintaining cost efficiency amid fluctuating sales. Overall, the revenue dynamics indicate a need for strategic adjustments to stabilize and enhance profitability.
Profitability and Efficiency Metrics
Thirumalai Chemicals has faced significant challenges regarding profitability, as evidenced by its reported net profit of -₹149 Cr for the TTM period. The company’s operating profit has also seen a downward trend, with a negative operating profit margin of -1% reported in September 2023. The quarterly operating profit fluctuated, reaching a low of -₹1 Cr in March 2023 and peaking at ₹61 Cr in September 2022. The interest coverage ratio stood at 1.41x, indicating that the company’s earnings are barely sufficient to cover its interest expenses, a concerning sign of financial strain. The return on equity (ROE) was recorded at 4.13%, substantially below the typical sector range, suggesting that shareholder returns are not being efficiently generated. Moreover, the cash conversion cycle of -11 days reflects a strong ability to manage working capital, but this efficiency has not translated into profitability, highlighting the need for improved operational effectiveness and cost management.
Balance Sheet Strength and Financial Ratios
The financial position of Thirumalai Chemicals reveals both strengths and vulnerabilities. As of September 2025, the company reported total borrowings of ₹2,086 Cr against reserves of ₹1,521 Cr, resulting in a high debt-to-equity ratio of 1.48, indicating potential over-leverage. The current ratio stood at 1.04, suggesting that the company can cover its short-term liabilities, albeit with limited buffer. The book value per share was ₹112.86, while the price-to-book value (P/BV) ratio was reported at 2.15x, indicating that the stock may be perceived as overvalued relative to its book value. Additionally, the interest coverage ratio of 1.41x raises concerns about the company’s ability to meet its interest obligations comfortably. Despite these challenges, the company’s fixed assets have increased to ₹1,281 Cr, reflecting ongoing investments in operational capacity. Nevertheless, the financial ratios indicate that Thirumalai Chemicals must address its debt levels and improve profitability to strengthen its balance sheet.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Thirumalai Chemicals shows a diverse ownership structure, with public shareholders holding 52.39% as of September 2025. Promoters have decreased their stake to 36.13%, down from 42.01% in December 2022, indicating a potential erosion of confidence among insiders. Foreign institutional investors (FIIs) hold a modest 2.15%, while domestic institutional investors (DIIs) have increased their stake to 9.32%, reflecting growing interest from local institutions amid the company’s operational challenges. The total number of shareholders has declined from 81,997 in December 2022 to 58,416 by September 2025, suggesting a potential exit of retail investors. This decline in shareholder numbers, combined with the reduction in promoter holdings, may signal waning confidence in the company’s future prospects. Investor sentiment appears cautious, necessitating strategic initiatives to rebuild trust and stabilize shareholder value.
Outlook, Risks, and Final Insight
The outlook for Thirumalai Chemicals is complex, characterized by significant risks and opportunities. The company must navigate its profitability challenges, as indicated by the negative net profits and operating margins. Additionally, high levels of debt pose a risk, particularly in a rising interest rate environment. The need for operational efficiency and cost management is critical, especially given the fluctuating sales patterns. On the upside, improvements in working capital management, as evidenced by the negative cash conversion cycle, present an opportunity for the company to enhance liquidity. If Thirumalai Chemicals can successfully implement cost-control measures and stabilize its revenue streams, it may regain investor confidence and improve profitability. Conversely, failure to address these challenges may lead to further declines in financial performance and shareholder value. Overall, Thirumalai Chemicals stands at a crossroads, where strategic decisions will be paramount in determining its future trajectory.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 377 Cr. | 41.1 | 63.6/35.0 | 23.5 | 20.5 | 0.97 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 31.0 Cr. | 63.2 | 88.8/52.0 | 15.1 | 89.6 | 1.58 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 49.6 Cr. | 729 | 899/600 | 16.7 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,324 Cr. | 73.3 | 111/68.2 | 22.0 | 22.0 | 0.68 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 633 Cr. | 256 | 357/208 | 24.2 | 93.8 | 0.98 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 13,111.56 Cr | 745.94 | 59.31 | 182.97 | 0.45% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 572 | 508 | 431 | 523 | 542 | 492 | 527 | 555 | 525 | 447 | 523 | 450 | 445 |
| Expenses | 511 | 479 | 432 | 485 | 527 | 498 | 523 | 524 | 502 | 467 | 508 | 477 | 449 |
| Operating Profit | 61 | 29 | -1 | 38 | 15 | -6 | 4 | 31 | 24 | -20 | 15 | -27 | -4 |
| OPM % | 11% | 6% | -0% | 7% | 3% | -1% | 1% | 6% | 4% | -5% | 3% | -6% | -1% |
| Other Income | 6 | 11 | 11 | 5 | 6 | 4 | 4 | 3 | 9 | 0 | 8 | 2 | 8 |
| Interest | 7 | 11 | 7 | 10 | 10 | 12 | 10 | 9 | 10 | 14 | 15 | 18 | 26 |
| Depreciation | 13 | 14 | 16 | 16 | 16 | 15 | 17 | 14 | 13 | 16 | 18 | 22 | 23 |
| Profit before tax | 47 | 14 | -13 | 17 | -4 | -29 | -19 | 11 | 9 | -50 | -11 | -64 | -44 |
| Tax % | 27% | 41% | 0% | 37% | 47% | -20% | 10% | 53% | 47% | -16% | 28% | -7% | -24% |
| Net Profit | 34 | 8 | -13 | 11 | -6 | -23 | -20 | 5 | 5 | -42 | -14 | -60 | -33 |
| EPS in Rs | 3.35 | 0.81 | -1.25 | 1.04 | -0.59 | -2.24 | -2.00 | 0.50 | 0.48 | -4.10 | -1.37 | -5.86 | -2.81 |
Last Updated: December 28, 2025, 8:04 pm
Below is a detailed analysis of the quarterly data for Thirumalai Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 445.00 Cr.. The value appears to be declining and may need further review. It has decreased from 450.00 Cr. (Jun 2025) to 445.00 Cr., marking a decrease of 5.00 Cr..
- For Expenses, as of Sep 2025, the value is 449.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 477.00 Cr. (Jun 2025) to 449.00 Cr., marking a decrease of 28.00 Cr..
- For Operating Profit, as of Sep 2025, the value is -4.00 Cr.. The value appears strong and on an upward trend. It has increased from -27.00 Cr. (Jun 2025) to -4.00 Cr., marking an increase of 23.00 Cr..
- For OPM %, as of Sep 2025, the value is -1.00%. The value appears strong and on an upward trend. It has increased from -6.00% (Jun 2025) to -1.00%, marking an increase of 5.00%.
- For Other Income, as of Sep 2025, the value is 8.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Jun 2025) to 8.00 Cr., marking an increase of 6.00 Cr..
- For Interest, as of Sep 2025, the value is 26.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 18.00 Cr. (Jun 2025) to 26.00 Cr., marking an increase of 8.00 Cr..
- For Depreciation, as of Sep 2025, the value is 23.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 22.00 Cr. (Jun 2025) to 23.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is -44.00 Cr.. The value appears strong and on an upward trend. It has increased from -64.00 Cr. (Jun 2025) to -44.00 Cr., marking an increase of 20.00 Cr..
- For Tax %, as of Sep 2025, the value is -24.00%. The value appears to be improving (decreasing) as expected. It has decreased from -7.00% (Jun 2025) to -24.00%, marking a decrease of 17.00%.
- For Net Profit, as of Sep 2025, the value is -33.00 Cr.. The value appears strong and on an upward trend. It has increased from -60.00 Cr. (Jun 2025) to -33.00 Cr., marking an increase of 27.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is -2.81. The value appears strong and on an upward trend. It has increased from -5.86 (Jun 2025) to -2.81, marking an increase of 3.05.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:30 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,275 | 1,070 | 940 | 1,028 | 1,312 | 1,261 | 1,085 | 1,086 | 1,998 | 2,132 | 2,083 | 2,050 | 1,865 |
| Expenses | 1,192 | 1,032 | 842 | 871 | 1,022 | 1,055 | 1,007 | 865 | 1,557 | 1,946 | 2,032 | 2,001 | 1,901 |
| Operating Profit | 83 | 38 | 98 | 158 | 290 | 206 | 78 | 221 | 441 | 186 | 51 | 49 | -36 |
| OPM % | 7% | 4% | 10% | 15% | 22% | 16% | 7% | 20% | 22% | 9% | 2% | 2% | -2% |
| Other Income | 3 | 8 | 5 | 4 | 7 | 12 | 21 | 7 | 12 | 30 | 19 | 21 | 19 |
| Interest | 49 | 35 | 23 | 17 | 13 | 12 | 17 | 21 | 20 | 31 | 42 | 49 | 74 |
| Depreciation | 23 | 18 | 25 | 36 | 31 | 36 | 44 | 50 | 57 | 56 | 63 | 61 | 78 |
| Profit before tax | 15 | -7 | 55 | 109 | 253 | 169 | 38 | 157 | 375 | 129 | -35 | -41 | -169 |
| Tax % | 20% | 102% | 41% | 35% | 33% | 33% | 39% | 25% | 25% | 31% | 12% | 13% | |
| Net Profit | 12 | -14 | 32 | 71 | 170 | 114 | 23 | 118 | 281 | 90 | -39 | -46 | -149 |
| EPS in Rs | 1.16 | -1.34 | 3.14 | 6.90 | 16.64 | 11.09 | 2.26 | 11.49 | 27.47 | 8.77 | -3.79 | -4.50 | -14.14 |
| Dividend Payout % | 0% | -30% | 51% | 27% | 12% | 18% | 0% | 19% | 9% | 17% | -26% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -216.67% | 328.57% | 121.88% | 139.44% | -32.94% | -79.82% | 413.04% | 138.14% | -67.97% | -143.33% | -17.95% |
| Change in YoY Net Profit Growth (%) | 0.00% | 545.24% | -206.70% | 17.56% | -172.38% | -46.88% | 492.87% | -274.91% | -206.11% | -75.36% | 125.38% |
Thirumalai Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 14% |
| 3 Years: | 1% |
| TTM: | -8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -151% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 36% |
| 3 Years: | 9% |
| 1 Year: | -8% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 8% |
| 3 Years: | 0% |
| Last Year: | -4% |
Last Updated: September 5, 2025, 1:46 pm
Balance Sheet
Last Updated: December 10, 2025, 3:33 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 12 |
| Reserves | 205 | 183 | 208 | 388 | 563 | 658 | 628 | 793 | 1,075 | 1,182 | 1,136 | 1,145 | 1,521 |
| Borrowings | 222 | 142 | 91 | 62 | 50 | 103 | 197 | 183 | 165 | 514 | 1,252 | 1,786 | 2,086 |
| Other Liabilities | 321 | 212 | 211 | 327 | 202 | 370 | 365 | 358 | 612 | 654 | 922 | 867 | 727 |
| Total Liabilities | 757 | 547 | 520 | 786 | 825 | 1,141 | 1,200 | 1,343 | 1,862 | 2,360 | 3,320 | 3,808 | 4,345 |
| Fixed Assets | 230 | 243 | 256 | 317 | 310 | 383 | 550 | 513 | 596 | 671 | 712 | 1,251 | 1,281 |
| CWIP | 18 | 7 | 18 | 9 | 44 | 159 | 82 | 126 | 64 | 406 | 1,200 | 1,352 | 1,740 |
| Investments | 5 | 5 | 5 | 77 | 104 | 150 | 49 | 136 | 180 | 132 | 173 | 200 | 210 |
| Other Assets | 503 | 291 | 241 | 383 | 367 | 449 | 519 | 569 | 1,022 | 1,150 | 1,236 | 1,005 | 1,114 |
| Total Assets | 757 | 547 | 520 | 786 | 825 | 1,141 | 1,200 | 1,343 | 1,862 | 2,360 | 3,320 | 3,808 | 4,345 |
Below is a detailed analysis of the balance sheet data for Thirumalai Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2025) to 12.00 Cr., marking an increase of 2.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,521.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,145.00 Cr. (Mar 2025) to 1,521.00 Cr., marking an increase of 376.00 Cr..
- For Borrowings, as of Sep 2025, the value is 2,086.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 1,786.00 Cr. (Mar 2025) to 2,086.00 Cr., marking an increase of 300.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 727.00 Cr.. The value appears to be improving (decreasing). It has decreased from 867.00 Cr. (Mar 2025) to 727.00 Cr., marking a decrease of 140.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 4,345.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,808.00 Cr. (Mar 2025) to 4,345.00 Cr., marking an increase of 537.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,281.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,251.00 Cr. (Mar 2025) to 1,281.00 Cr., marking an increase of 30.00 Cr..
- For CWIP, as of Sep 2025, the value is 1,740.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,352.00 Cr. (Mar 2025) to 1,740.00 Cr., marking an increase of 388.00 Cr..
- For Investments, as of Sep 2025, the value is 210.00 Cr.. The value appears strong and on an upward trend. It has increased from 200.00 Cr. (Mar 2025) to 210.00 Cr., marking an increase of 10.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,114.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,005.00 Cr. (Mar 2025) to 1,114.00 Cr., marking an increase of 109.00 Cr..
- For Total Assets, as of Sep 2025, the value is 4,345.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,808.00 Cr. (Mar 2025) to 4,345.00 Cr., marking an increase of 537.00 Cr..
However, the Borrowings (2,086.00 Cr.) are higher than the Reserves (1,521.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -139.00 | -104.00 | 7.00 | 96.00 | 240.00 | 103.00 | -119.00 | 38.00 | 276.00 | -328.00 | 50.00 | 48.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 66 | 52 | 50 | 49 | 33 | 33 | 30 | 29 | 29 | 17 | 32 | 35 |
| Inventory Days | 74 | 42 | 38 | 82 | 59 | 84 | 69 | 74 | 74 | 76 | 55 | 57 |
| Days Payable | 59 | 38 | 92 | 139 | 53 | 119 | 123 | 129 | 141 | 118 | 113 | 103 |
| Cash Conversion Cycle | 82 | 56 | -3 | -8 | 39 | -2 | -24 | -26 | -39 | -25 | -26 | -11 |
| Working Capital Days | 3 | -8 | -15 | -5 | 37 | 4 | -5 | -19 | -23 | -61 | -93 | -57 |
| ROCE % | 14% | 7% | 24% | 33% | 49% | 26% | 7% | 20% | 35% | 11% | 0% | 0% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Motilal Oswal Small Cap Fund | 3,068,592 | 1.22 | 70.97 | 3,068,592 | 2026-02-13 17:13:02 | 0% |
| Motilal Oswal Multi Cap Fund | 2,797,833 | 1.43 | 64.71 | N/A | N/A | N/A |
| Motilal Oswal Business Cycle Fund | 1,353,790 | 1.48 | 31.31 | N/A | N/A | N/A |
| Motilal Oswal Small Cap Fund | 1,083,586 | 0.44 | 25.57 | 3,068,592 | 2026-02-13 17:13:02 | -64.69% |
| Bandhan Small Cap Fund | 600,274 | 0.07 | 14.17 | 577,617 | 2025-12-15 06:52:35 | 3.92% |
| ICICI Prudential Commodities Fund | 571,973 | 0.4 | 13.5 | 499,582 | 2026-01-26 07:43:57 | 14.49% |
| Bandhan Balanced Advantage Fund | 361,010 | 0.37 | 8.52 | N/A | N/A | N/A |
| Bandhan Business Cycle Fund | 361,010 | 0.59 | 8.52 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | -4.50 | -3.79 | 8.77 | 27.46 | 11.49 |
| Diluted EPS (Rs.) | -4.50 | -3.79 | 8.77 | 27.46 | 11.49 |
| Cash EPS (Rs.) | 1.46 | 2.38 | 14.21 | 32.99 | 16.33 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 112.86 | 111.93 | 116.40 | 105.96 | 78.41 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 112.86 | 111.93 | 116.40 | 105.96 | 78.41 |
| Revenue From Operations / Share (Rs.) | 200.15 | 203.43 | 208.23 | 195.14 | 106.03 |
| PBDIT / Share (Rs.) | 6.78 | 6.87 | 21.13 | 44.18 | 22.22 |
| PBIT / Share (Rs.) | 0.81 | 0.69 | 15.69 | 38.65 | 17.39 |
| PBT / Share (Rs.) | -3.99 | -3.37 | 12.64 | 36.66 | 15.34 |
| Net Profit / Share (Rs.) | -4.50 | -3.79 | 8.77 | 27.46 | 11.49 |
| NP After MI And SOA / Share (Rs.) | -4.50 | -3.79 | 8.77 | 27.46 | 11.49 |
| PBDIT Margin (%) | 3.38 | 3.37 | 10.14 | 22.63 | 20.95 |
| PBIT Margin (%) | 0.40 | 0.34 | 7.53 | 19.80 | 16.39 |
| PBT Margin (%) | -1.99 | -1.65 | 6.06 | 18.78 | 14.47 |
| Net Profit Margin (%) | -2.24 | -1.86 | 4.21 | 14.07 | 10.83 |
| NP After MI And SOA Margin (%) | -2.24 | -1.86 | 4.21 | 14.07 | 10.83 |
| Return on Networth / Equity (%) | -3.98 | -3.38 | 7.53 | 25.91 | 14.65 |
| Return on Capital Employeed (%) | 0.28 | 0.31 | 10.74 | 30.29 | 17.08 |
| Return On Assets (%) | -1.21 | -1.16 | 3.80 | 15.10 | 8.76 |
| Long Term Debt / Equity (X) | 1.21 | 0.70 | 0.12 | 0.12 | 0.19 |
| Total Debt / Equity (X) | 1.48 | 1.01 | 0.37 | 0.14 | 0.19 |
| Asset Turnover Ratio (%) | 0.57 | 0.73 | 1.01 | 1.02 | 0.73 |
| Current Ratio (X) | 1.04 | 1.10 | 1.22 | 1.86 | 1.90 |
| Quick Ratio (X) | 0.77 | 0.85 | 0.84 | 1.42 | 1.47 |
| Inventory Turnover Ratio (X) | 8.23 | 7.31 | 5.40 | 5.68 | 3.91 |
| Dividend Payout Ratio (NP) (%) | -22.21 | -39.59 | 28.49 | 8.01 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 68.26 | 62.92 | 17.59 | 6.66 | 0.00 |
| Earning Retention Ratio (%) | 122.21 | 139.59 | 71.51 | 91.99 | 0.00 |
| Cash Earning Retention Ratio (%) | 31.74 | 37.08 | 82.41 | 93.34 | 0.00 |
| Interest Coverage Ratio (X) | 1.41 | 1.69 | 6.92 | 22.21 | 10.88 |
| Interest Coverage Ratio (Post Tax) (X) | 0.06 | 0.07 | 3.87 | 14.81 | 6.63 |
| Enterprise Value (Cr.) | 3836.01 | 2961.10 | 1656.34 | 2334.91 | 725.01 |
| EV / Net Operating Revenue (X) | 1.87 | 1.42 | 0.77 | 1.17 | 0.66 |
| EV / EBITDA (X) | 55.27 | 42.09 | 7.66 | 5.16 | 3.19 |
| MarketCap / Net Operating Revenue (X) | 1.21 | 1.15 | 0.82 | 1.36 | 0.80 |
| Retention Ratios (%) | 122.21 | 139.59 | 71.50 | 91.98 | 0.00 |
| Price / BV (X) | 2.15 | 2.09 | 1.48 | 2.51 | 1.09 |
| Price / Net Operating Revenue (X) | 1.21 | 1.15 | 0.82 | 1.36 | 0.80 |
| EarningsYield | -0.01 | -0.01 | 0.05 | 0.10 | 0.13 |
After reviewing the key financial ratios for Thirumalai Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -4.50. This value is below the healthy minimum of 5. It has decreased from -3.79 (Mar 24) to -4.50, marking a decrease of 0.71.
- For Diluted EPS (Rs.), as of Mar 25, the value is -4.50. This value is below the healthy minimum of 5. It has decreased from -3.79 (Mar 24) to -4.50, marking a decrease of 0.71.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.46. This value is below the healthy minimum of 3. It has decreased from 2.38 (Mar 24) to 1.46, marking a decrease of 0.92.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 112.86. It has increased from 111.93 (Mar 24) to 112.86, marking an increase of 0.93.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 112.86. It has increased from 111.93 (Mar 24) to 112.86, marking an increase of 0.93.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 200.15. It has decreased from 203.43 (Mar 24) to 200.15, marking a decrease of 3.28.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 6.78. This value is within the healthy range. It has decreased from 6.87 (Mar 24) to 6.78, marking a decrease of 0.09.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.81. This value is within the healthy range. It has increased from 0.69 (Mar 24) to 0.81, marking an increase of 0.12.
- For PBT / Share (Rs.), as of Mar 25, the value is -3.99. This value is below the healthy minimum of 0. It has decreased from -3.37 (Mar 24) to -3.99, marking a decrease of 0.62.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -4.50. This value is below the healthy minimum of 2. It has decreased from -3.79 (Mar 24) to -4.50, marking a decrease of 0.71.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -4.50. This value is below the healthy minimum of 2. It has decreased from -3.79 (Mar 24) to -4.50, marking a decrease of 0.71.
- For PBDIT Margin (%), as of Mar 25, the value is 3.38. This value is below the healthy minimum of 10. It has increased from 3.37 (Mar 24) to 3.38, marking an increase of 0.01.
- For PBIT Margin (%), as of Mar 25, the value is 0.40. This value is below the healthy minimum of 10. It has increased from 0.34 (Mar 24) to 0.40, marking an increase of 0.06.
- For PBT Margin (%), as of Mar 25, the value is -1.99. This value is below the healthy minimum of 10. It has decreased from -1.65 (Mar 24) to -1.99, marking a decrease of 0.34.
- For Net Profit Margin (%), as of Mar 25, the value is -2.24. This value is below the healthy minimum of 5. It has decreased from -1.86 (Mar 24) to -2.24, marking a decrease of 0.38.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -2.24. This value is below the healthy minimum of 8. It has decreased from -1.86 (Mar 24) to -2.24, marking a decrease of 0.38.
- For Return on Networth / Equity (%), as of Mar 25, the value is -3.98. This value is below the healthy minimum of 15. It has decreased from -3.38 (Mar 24) to -3.98, marking a decrease of 0.60.
- For Return on Capital Employeed (%), as of Mar 25, the value is 0.28. This value is below the healthy minimum of 10. It has decreased from 0.31 (Mar 24) to 0.28, marking a decrease of 0.03.
- For Return On Assets (%), as of Mar 25, the value is -1.21. This value is below the healthy minimum of 5. It has decreased from -1.16 (Mar 24) to -1.21, marking a decrease of 0.05.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 1.21. This value exceeds the healthy maximum of 1. It has increased from 0.70 (Mar 24) to 1.21, marking an increase of 0.51.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.48. This value exceeds the healthy maximum of 1. It has increased from 1.01 (Mar 24) to 1.48, marking an increase of 0.47.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.57. It has decreased from 0.73 (Mar 24) to 0.57, marking a decrease of 0.16.
- For Current Ratio (X), as of Mar 25, the value is 1.04. This value is below the healthy minimum of 1.5. It has decreased from 1.10 (Mar 24) to 1.04, marking a decrease of 0.06.
- For Quick Ratio (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1. It has decreased from 0.85 (Mar 24) to 0.77, marking a decrease of 0.08.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.23. This value exceeds the healthy maximum of 8. It has increased from 7.31 (Mar 24) to 8.23, marking an increase of 0.92.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is -22.21. This value is below the healthy minimum of 20. It has increased from -39.59 (Mar 24) to -22.21, marking an increase of 17.38.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 68.26. This value exceeds the healthy maximum of 50. It has increased from 62.92 (Mar 24) to 68.26, marking an increase of 5.34.
- For Earning Retention Ratio (%), as of Mar 25, the value is 122.21. This value exceeds the healthy maximum of 70. It has decreased from 139.59 (Mar 24) to 122.21, marking a decrease of 17.38.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 31.74. This value is below the healthy minimum of 40. It has decreased from 37.08 (Mar 24) to 31.74, marking a decrease of 5.34.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.41. This value is below the healthy minimum of 3. It has decreased from 1.69 (Mar 24) to 1.41, marking a decrease of 0.28.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 3. It has decreased from 0.07 (Mar 24) to 0.06, marking a decrease of 0.01.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,836.01. It has increased from 2,961.10 (Mar 24) to 3,836.01, marking an increase of 874.91.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.87. This value is within the healthy range. It has increased from 1.42 (Mar 24) to 1.87, marking an increase of 0.45.
- For EV / EBITDA (X), as of Mar 25, the value is 55.27. This value exceeds the healthy maximum of 15. It has increased from 42.09 (Mar 24) to 55.27, marking an increase of 13.18.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has increased from 1.15 (Mar 24) to 1.21, marking an increase of 0.06.
- For Retention Ratios (%), as of Mar 25, the value is 122.21. This value exceeds the healthy maximum of 70. It has decreased from 139.59 (Mar 24) to 122.21, marking a decrease of 17.38.
- For Price / BV (X), as of Mar 25, the value is 2.15. This value is within the healthy range. It has increased from 2.09 (Mar 24) to 2.15, marking an increase of 0.06.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has increased from 1.15 (Mar 24) to 1.21, marking an increase of 0.06.
- For EarningsYield, as of Mar 25, the value is -0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded -0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Thirumalai Chemicals Ltd:
- Net Profit Margin: -2.24%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0.28% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -3.98% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.06
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.77
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 59.31)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.48
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -2.24%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Thirumalai House, Mumbai Maharashtra 400022 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. R Parthasarathy | Chairman & Managing Director |
| Mrs. Ramya Bharathram | Managing Director & CFO |
| Mr. P Mohana Chandran Nair | Director |
| Mr. Arun Alagappan | Director |
| Mrs. Bhama Krishnamurthy | Director |
| Mr. Arun Ramanathan | Director |
| Mr. R Sampath | Director |
| Mr. Rajeev M Pandia | Director |
| Mr. M Somasundaram | Director |
FAQ
What is the intrinsic value of Thirumalai Chemicals Ltd?
Thirumalai Chemicals Ltd's intrinsic value (as of 13 February 2026) is ₹30.79 which is 85.68% lower the current market price of ₹215.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹2,589 Cr. market cap, FY2025-2026 high/low of ₹329/178, reserves of ₹1,521 Cr, and liabilities of ₹4,345 Cr.
What is the Market Cap of Thirumalai Chemicals Ltd?
The Market Cap of Thirumalai Chemicals Ltd is 2,589 Cr..
What is the current Stock Price of Thirumalai Chemicals Ltd as on 13 February 2026?
The current stock price of Thirumalai Chemicals Ltd as on 13 February 2026 is ₹215.
What is the High / Low of Thirumalai Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Thirumalai Chemicals Ltd stocks is ₹329/178.
What is the Stock P/E of Thirumalai Chemicals Ltd?
The Stock P/E of Thirumalai Chemicals Ltd is .
What is the Book Value of Thirumalai Chemicals Ltd?
The Book Value of Thirumalai Chemicals Ltd is 129.
What is the Dividend Yield of Thirumalai Chemicals Ltd?
The Dividend Yield of Thirumalai Chemicals Ltd is 0.00 %.
What is the ROCE of Thirumalai Chemicals Ltd?
The ROCE of Thirumalai Chemicals Ltd is 0.26 %.
What is the ROE of Thirumalai Chemicals Ltd?
The ROE of Thirumalai Chemicals Ltd is 4.13 %.
What is the Face Value of Thirumalai Chemicals Ltd?
The Face Value of Thirumalai Chemicals Ltd is 1.00.